REQUEST A DEMO
Total
USD $0.00
Search more companies

Bb Pharma S.R.O. (Slovakia)

Main Activities: Pharmaceutical and Medicine Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bb Pharma S.R.O. Profile Updated: October 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Bb Pharma S.R.O. is an enterprise located in Slovakia, with the main office in Martin. It operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on October 22, 1993. It currently has a total number of 10 - 19 (2023) employees. The company’s latest financial report indicates a net sales revenue increase of 27.81% in 2023. Its’ total assets recorded a growth of 0.57%. In 2023, Bb Pharma S.R.O.’s net profit margin decreased by 3.59%.

Headquarters
Sklabinska, 30
Martin; Zilinsky; Postal Code: 03601

Contact Details: Purchase the Bb Pharma S.R.O. report to view the information.

Website: http://www.bbpharma.sk/

Basic Information
Total Employees:
Purchase the Bb Pharma S.R.O. report to view the information.
Outstanding Shares:
Purchase the Bb Pharma S.R.O. report to view the information.
Registered Capital:
Purchase the Bb Pharma S.R.O. report to view the information.
Incorporation Date:
October 22, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Bb Pharma S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
27.81%
Total operating revenue
12.33%
Operating profit (EBIT)
-17.55%
EBITDA
-15.64%
Net Profit (Loss) for the Period
-29.34%
Total assets
0.57%
Total equity
3.24%
Operating Profit Margin (ROS)
-3.57%
Net Profit Margin
-3.59%
Return on Equity (ROE)
-3.84%
Debt to Equity Ratio
-0.96%
Quick Ratio
0.11%
Cash Ratio
0.14%

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?